Adial Pharmaceuticals Statistics
Total Valuation
ADIL has a market cap or net worth of $4.44 million. The enterprise value is $1.96 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ADIL has 6.57 million shares outstanding. The number of shares has increased by 202.76% in one year.
Current Share Class | 6.57M |
Shares Outstanding | 6.57M |
Shares Change (YoY) | +202.76% |
Shares Change (QoQ) | +1.94% |
Owned by Insiders (%) | 1.31% |
Owned by Institutions (%) | 3.62% |
Float | 6.15M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.06 |
P/TBV Ratio | 2.04 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.99
Current Ratio | 1.99 |
Quick Ratio | 1.79 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -217.01% and return on invested capital (ROIC) is -131.95%.
Return on Equity (ROE) | -217.01% |
Return on Assets (ROA) | -107.38% |
Return on Invested Capital (ROIC) | -131.95% |
Return on Capital Employed (ROCE) | -409.41% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.79M |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.13% in the last 52 weeks. The beta is 1.21, so ADIL's price volatility has been higher than the market average.
Beta (5Y) | 1.21 |
52-Week Price Change | -56.13% |
50-Day Moving Average | 0.69 |
200-Day Moving Average | 0.91 |
Relative Strength Index (RSI) | 50.69 |
Average Volume (20 Days) | 1,687,099 |
Short Selling Information
The latest short interest is 139,831, so 2.13% of the outstanding shares have been sold short.
Short Interest | 139,831 |
Short Previous Month | 217,057 |
Short % of Shares Out | 2.13% |
Short % of Float | 2.28% |
Short Ratio (days to cover) | 3.22 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -8.71M |
Pretax Income | -8.69M |
Net Income | -8.95M |
EBITDA | -8.71M |
EBIT | -8.71M |
Earnings Per Share (EPS) | -$1.56 |
Full Income Statement Balance Sheet
The company has $2.37 million in cash and n/a in debt, giving a net cash position of $2.37 million or $0.36 per share.
Cash & Cash Equivalents | 2.37M |
Total Debt | n/a |
Net Cash | 2.37M |
Net Cash Per Share | $0.36 |
Equity (Book Value) | 2.13M |
Book Value Per Share | 0.32 |
Working Capital | 1.30M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -6.88M |
Capital Expenditures | n/a |
Free Cash Flow | -6.88M |
FCF Per Share | -$1.05 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ADIL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -202.76% |
Shareholder Yield | -202.76% |
Earnings Yield | -206.94% |
FCF Yield | -159.12% |
Analyst Forecast
The average price target for ADIL is $8.00, which is 1,085.01% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.00 |
Price Target Difference | 1,085.01% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Aug 7, 2023 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |